SCHEMBL19687213

SCHEMBL19687213

O=Nc1ccc(/C=C/CO)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ RECQL P46063 1/20 0.47
▸ HSD17B10 Q99714 3/20 0.43
▸ PAM P19021 1/20 0.35
▸ TSHR P16473 2/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ CYP4F2 P78329 1/20 0.33
▸ CYP4A11 Q02928 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ MAOB P27338 2/20 0.31
▸ AKR1B10 O60218 1/20 0.31
▸ AKR1B1 P15121 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ GLO1 Q04760 1/20 0.31
▸ CAMK2A Q9UQM7 1/20 0.31
▸ CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9276381 0.82 ALDH1A1 (0.62) ALDH1A1CYP3A4RECQLHSD17B10PAM
SCHEMBL9276383 0.82 ALDH1A1 (0.62) ALDH1A1CYP3A4RECQLHSD17B10PAM
SCHEMBL17654903 0.79 ALDH1A1 (0.39) ALDH1A1CYP3A4HSD17B10PAMTSHR
SCHEMBL18657175 0.79 ALDH1A1 (0.39) ALDH1A1CYP3A4HSD17B10PAMTSHR
SCHEMBL13100598 0.78 HDAC8 (0.46) ALDH1A1CYP3A4HSD17B10TSHRTP53
SCHEMBL13583036 0.76 ALDH1A1 (0.52) ALDH1A1CYP3A4RECQLHSD17B10PAM
SCHEMBL13583034 0.76 ALDH1A1 (0.52) ALDH1A1CYP3A4RECQLHSD17B10PAM
SCHEMBL20079988 0.74 ALDH1A1 (0.36) ALDH1A1HSD17B10PAMTSHRTP53
SCHEMBL20079993 0.73 NPC1 (0.39) ALDH1A1CYP3A4RECQLHSD17B10TP53
SCHEMBL221967 0.73 ALDH1A1 (0.59) ALDH1A1CYP3A4RECQLHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170349561-A1 SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS UNITED STATES DEPARTMENT OF ENERGY 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349561-A1 SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS LSS, DCXR, MYB ALDH1A1 2369/4885CYP3A4 1965/4885RECQL 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback